CLINICAL ROLE -
NCPA Announces Staff Appointments to Strengthen Advocacy Efforts
Read More
Heart Disease Costs Projected to Skyrocket by 2035
A new report highlights the need for changes to reduce incidences of cardiovascular disease.
State Calls for Increased Transparency of Pharmaceutical Industry
Legislation would require manufacturers to disclose costs associated with certain drugs.
Investigational Cancer Drug May Prevent Heart Failure
A porcupine inhibitor may regenerate heart tissue after a heart attack and prevent heart failure.
Progress in the Quest for an HIV Cure
Statins among promising treatment options helping to progress the HIV treatment landscape.
Tongue Stimulation Plus Cognitive, Physical Rehabilitation Induces Neuroplasticity in Multiple Sclerosis
Central nervous system lesions may impede cognitive and sensorimotor function in patients with MS.
HIV Capsid Inhibitors Show Potential as Long-Acting Antiretroviral Treatment
Novel class of inhibitors may be used as a preventive measure for HIV in the future.
Long-Term Remission Seen with Experimental Stem Cell Treatment for Multiple Sclerosis
A majority of patients with multiple sclerosis treated with chemotherapy and a stem cell transplant remained in remission for at least 5 years.
FDA Grants Expanded Indication for Lenalidomide in Treatment of Multiple Myeloma
Lenalidomide (Revlimid) maintenance improved survival in multiple myeloma patients following a stem cell transplant.
FDA Approves Expanded Indication of Multiple Myeloma Drug
Revlimid is the only FDA-approved maintenance therapy for multiple myeloma following stem cell transplant.
Fish Oil May be a Viable Option for Asthma Treatment
Treatment with omega-3 reduces levels of IgE antibodies to reduce the risk of asthma flare-ups.
Stem Cell-Derived Therapy Successfully Treats Glioblastoma
Engineered stem cells can effectively target and kill brain cancer cells.
Why Are Some Patients Unresponsive to Immunotherapy?
Tumors containing JAK1 and JAK2 mutations effect response to immunotherapy in patients with melanoma and colon cancer.
FDA Grants Zykadia Breakthrough Designation for Lung Cancer
Application filed for ceritinib (Zykadia) as a first-line treatment for patients with metastatic non-small cell lung cancer.
Trending News Today: State Proposes Huge Funding Cuts for Public Health Programs
Top news of the day from across the health care landscape.
Lung Cancer Drug Granted Breakthrough Designation
Zykadia granted breakthrough therapy designation for ALK+ metastatic non-small cell lung cancer with brain metastases.
Trending News Today: Heart Screenings in Teens May Do More Harm Than Good
Top news of the day from across the healthcare landscape.
Lung Cancer Drug Receives FDA Priority Review
The FDA has accepted Novartis’ supplemental new drug application (sNDA) for filing and granted priority review for the expanded use of a new cancer drug.
Drug Shortages: Manufacturer Accountability Increasing
All over the world, drug shortages cause complex and risky adjustments to medical regimens.
5 Interesting Medication Case Reports - Part 2
This article highlights 5 published case reports that document medications causing unusual side effects that have not been readily seen in the literature.
Quick Diabetes Screening Guide to Assist Pharmacists in MTM
The use of MTM is expanding in the world of pharmacy. This article gives you a quick idea on what to screen for and address when analyzing a diabetic patients medication profile.
Tips for Ranking Residency Programs
As The Match approaches, it is important to consider specific things when dertermining your rank list
How Well Do You Know the Grapefruit Drug Interaction?
There is more to the grapefruit drug interaction than eating one kind of fruit.
New Records to Be Set At 2017 NACDS RxIMPACT Day on Capitol Hill
APhA Foundation Announces 2017-2018 Executive Resident
The American Pharmacists Association (APhA) Foundation has announced Jing Wu as the 2017-2018 Knowlton Center Executive Resident in Association Management and Leadership.
Diabetic Retinopathy: Updated Guidelines Reflect Improved Assessment and Treatment
The American Diabetes Association (ADA) released their first position statement in 15 years regarding diabetic retinopathy.
NASP President Discusses the Role of Specialty Pharmacy in the Health Care Ecosystem
The second of a 2-part interview with National Association of Specialty Pharmacy President Rebecca Shanahan on the hottest issues in specialty pharmacy.
Walking Improves Quality of Life in Patients with Advanced Cancer
Physical activity drops during and after cancer treatment.
Body Type May Influence Diabetes, Heart Disease Risks
Abdominal adiposity seen to increase the risk of type 2 diabetes, coronary heart disease, and cardiovascular risk factors.
Novel Treatment Reverses Inflammatory Response in COPD Mouse Models
Potential drug may have a protective role in chronic obstructive pulmonary disease.
